Implications of microRNAs in the pathogenesis of diabetes

Archives of Pharmacal Research

Volumn 36, Issue 2, 2013, Pages 154-166

  Park, Seung Yoon ^a   Jeong, Hyo Jin ^a   Yang, Won Mo ^a   Lee, Wan ^a  

^a Dongguk University College of Medicine   (South Korea)

Author keywords

Diabetes; Insulin resistance; Metabolic disease; MicroRNA

Indexed keywords

ARGONAUTE PROTEIN; GLUCOSE TRANSPORTER 4; INTERLEUKIN 1BETA; MICRORNA; MICRORNA 1; MICRORNA 107; MICRORNA 122; MICRORNA 124; MICRORNA 126; MICRORNA 143; MICRORNA 144; MICRORNA 146A; MICRORNA 15A; MICRORNA 20B; MICRORNA 222; MICRORNA 223; MICRORNA 24; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; MICRORNA 33; MICRORNA 34A; MICRORNA 370; MICRORNA 375; MITOGEN ACTIVATED PROTEIN KINASE 7; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA 2; SIRTUIN 1; SNARE PROTEIN; SYNAPTOBREVIN 2; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOGENESIS; ADIPOSE TISSUE; APOPTOSIS; BIOGENESIS; BODY MASS; CELL DIFFERENTIATION; CELL PROLIFERATION; CHROMOSOME 2; DIABETES MELLITUS; ENERGY METABOLISM; ENZYME PHOSPHORYLATION; EXOCYTOSIS; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FIBROSIS; GENE DELETION; GENE EXPRESSION; GENE SILENCING; GLUCAGON BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; HEART DISEASE; HUMAN; HYPERGLYCEMIA; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN SYNTHESIS; KIDNEY DISEASE; LIPID METABOLISM; LIVER CELL CARCINOMA; LIVER FUNCTION; LOSS OF FUNCTION MUTATION; METABOLIC REGULATION; MUSCLE DEVELOPMENT; MUSCLE METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXYGEN CONSUMPTION; PANCREAS ISLET BETA CELL; PATHOGENESIS; REVIEW; RNA BINDING; SECRETORY VESICLE; UPREGULATION;

EID: 84879505852     PISSN: 02536269     EISSN: 19763786     Source Type: Journal    
DOI: 10.1007/s12272-013-0017-6     Document Type: Review

References (110)

1. Avnit-Sagi, T.; L. Kantorovich, S. Kredo-Russo, E. Hornstein, and M.D. Walker. 2009. The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas. PLoS One 4: e5033.
2. Baroukh, N.; M.A. Ravier, M.K. Loder, E.V. Hill, A. Bounacer, R. Scharfmann, G.A. Rutter, and E. Van Obberghen. 2007. MicroRNA-124a regulates Foxa2 expression and intracellular signaling in pancreatic beta-cell lines. The Journal of Biological Chemistry 282: 19575-19588.
3. Baroukh, N.N.; and E. Van Obberghen. 2009. Function of microRNA-375 and microRNA-124a in pancreas and brain. The FEBS Journal 276: 6509-6521.
4. Bartel, D.P. 2009. MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
5. Borchert, G.M.; W. Lanier, and B.L. Davidson. 2006. RNA polymerase III transcribes human microRNAs. Nature Structural & Molecular Biology 13: 1097-1101.
6. Bornfeldt, K.E.; and I. Tabas. 2011. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metabolism 14: 575-585.
7. Brunham, L.R.; J.K. Kruit, C.B. Verchere, and M.R. Hayden. 2008. Cholesterol in islet dysfunction and type 2 diabetes. The Journal of Clinical Investigation 118: 403-408.
8. Carrer, M.; N. Liu, C.E. Grueter, A.H. Williams, M.I. Frisard, M.W. Hulver, R. Bassel-Duby, and E.N. Olson. 2012. Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378. Proceedings of the National Academy of Sciences of the United States of America 109: 15330-15335.
9. Chang, J.; E. Nicolas, D. Marks, C. Sander, A. Lerro, M.A. Buendia, C. Xu, W.S. Mason, T. Moloshok, R. Bort, K.S. Zaret, and J.M. Taylor. 2004. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biology 1: 106-113.
10. Chendrimada, T.P.; R.I. Gregory, E. Kumaraswamy, J. Norman, N. Cooch, K. Nishikura, and R. Shiekhattar. 2005. TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature 436: 740-744.
11. Cheviet, S.; T. Coppola, L.P. Haynes, R.D. Burgoyne, and R. Regazzi. 2004. The Rab-binding protein Noc2 is associated with insulin-containing secretory granules and is essential for pancreatic beta-cell exocytosis. Molecular Endocrinology 18: 117-126.
12. Cobelli, C.; E. Renard, and B. Kovatchev. 2011. Artificial pancreas: Past, present, future. Diabetes 60: 2672-2682.
13. Cuellar, T.L.; and M.T. Mcmanus. 2005. MicroRNAs and endocrine biology. The Journal of Endocrinology 187: 327-332.
14. Davalos, A.; L. Goedeke, P. Smibert, C.M. Ramirez, N.P. Warrier, U. Andreo, D. Cirera-Salinas, K. Rayner, U. Suresh, J.C. Pastor-Pareja, E. Esplugues, E.A. Fisher, L.O. Penalva, K.J. Moore, Y. Suarez, E.C. Lai, and C. Fernandez-Hernando. 2011. miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling. Proceedings of the National Academy of Sciences of the United States of America 108: 9232-9237.
15. Denli, A.M.; B.B. Tops, R.H. Plasterk, R.F. Ketting, and G.J. Hannon. 2004. Processing of primary microRNAs by the Microprocessor complex. Nature 432: 231-235.
16. Donath, M.Y.; J.A. Ehses, K. Maedler, D.M. Schumann, H. Ellingsgaard, E. Eppler, and M. Reinecke. 2005. Mechanisms of beta-cell death in type 2 diabetes. Diabetes 54(Suppl 2): S108-S113.
17. Elia, L.; R. Contu, M. Quintavalle, F. Varrone, C. Chimenti, M.A. Russo, V. Cimino, L. De Marinis, A. Frustaci, D. Catalucci, and G. Condorelli. 2009. Reciprocal regulation of microRNA-1 and insulin-like growth factor-1 signal transduction cascade in cardiac and skeletal muscle in physiological and pathological conditions. Circulation 120: 2377-2385.
18. Elmen, J.; M. Lindow, S. Schutz, M. Lawrence, A. Petri, S. Obad, M. Lindholm, M. Hedtjarn, H.F. Hansen, U. Berger, S. Gullans, P. Kearney, P. Sarnow, E.M. Straarup, and S. Kauppinen. 2008. LNA-mediated microRNA silencing in non-human primates. Nature 452: 896-899.
19. Esau, C.; S. Davis, S.F. Murray, X.X. Yu, S.K. Pandey, M. Pear, L. Watts, S.L. Booten, M. Graham, R. Mckay, A. Subramaniam, S. Propp, B.A. Lollo, S. Freier, C.F. Bennett, S. Bhanot, and B.P. Monia. 2006. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metabolism 3: 87-98.
20. Esau, C.; X. Kang, E. Peralta, E. Hanson, E.G. Marcusson, L.V. Ravichandran, Y. Sun, S. Koo, R.J. Perera, R. Jain, N.M. Dean, S.M. Freier, C.F. Bennett, B. Lollo, and R. Griffey. 2004. MicroRNA-143 regulates adipocyte differentiation. The Journal of Biological Chemistry 279: 52361-52365.
21. Ferland-Mccollough, D.; S.E. Ozanne, K. Siddle, A.E. Willis, and M. Bushell. 2010. The involvement of microRNAs in type 2 diabetes. Biochemical Society Transactions 38: 1565-1570.
22. Fernandez-Hernando, C.; Y. Suarez, K.J. Rayner, and K.J. Moore. 2011. MicroRNAs in lipid metabolism. Current Opinion in Lipidology 22: 86-92.
23. Gallagher, I.J.; C. Scheele, P. Keller, A.R. Nielsen, J. Remenyi, C.P. Fischer, K. Roder, J. Babraj, C. Wahlestedt, G. Hutvagner, B.K. Pedersen, and J.A. Timmons. 2010. Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Medicine 2: 9.
24. Gerin, I.; G.T. Bommer, C.S. Mccoin, K.M. Sousa, V. Krishnan, and O.A. Macdougald. 2010. Roles for miRNA-378/378*in adipocyte gene expression and lipogenesis. American Journal of Physiology, Endocrinology and Metabolism 299: E198-E206.
25. Granjon, A.; M.P. Gustin, J. Rieusset, E. Lefai, E. Meugnier, I. Guller, C. Cerutti, C. Paultre, E. Disse, R. Rabasa-Lhoret, M. Laville, H. Vidal, and S. Rome. 2009. The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway. Diabetes 58: 2555-2564.
26. Gregory, R.I.; T.P. Chendrimada, N. Cooch, and R. Shiekhattar. 2005. Human RISC couples microRNA biogenesis and posttranscriptional gene silencing. Cell 123: 631-640.
27. Gregory, R.I.; K.P. Yan, G. Amuthan, T. Chendrimada, B. Doratotaj, N. Cooch, and R. Shiekhattar. 2004. The microprocessor complex mediates the genesis of microRNAs. Nature 432: 235-240.
28. Guay, C.; E. Roggli, V. Nesca, C. Jacovetti, and R. Regazzi. 2011. Diabetes mellitus, a microRNA-related disease? Translational Research 157: 253-264.
29. Guo, C.; J.F. Sah, L. Beard, J.K. Willson, S.D. Markowitz, and K. Guda. 2008. The noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancers. Genes, Chromosomes and Cancer 47: 939-946.
30. Han, J.; Y. Lee, K.H. Yeom, Y.K. Kim, H. Jin, and V.N. Kim. 2004. The Drosha-DGCR8 complex in primary microRNA processing. Genes & Development 18: 3016-3027.
31. Hardy, O.T.; M.P. Czech, and S. Corvera. 2012. What causes the insulin resistance underlying obesity? Current Opinion in Endocrinology, Diabetes, and Obesity 19: 81-87.
32. He, A.; L. Zhu, N. Gupta, Y. Chang, and F. Fang. 2007. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Molecular Endocrinology 21: 2785-2794.
33. Hennessy, E.; and L. O'driscoll. 2008. Molecular medicine of microRNAs: structure, function and implications for diabetes. Expert Reviews in Molecular Medicine 10: e24.
34. Herrera, B.M.; H.E. Lockstone, J.M. Taylor, M. Ria, A. Barrett, S. Collins, P. Kaisaki, K. Argoud, C. Fernandez, M.E. Travers, J.P. Grew, J.C. Randall, A.L. Gloyn, D. Gauguier, M.I. Mccarthy, and C.M. Lindgren. 2010. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia 53: 1099-1109.
35. Herrera, B.M.; H.E. Lockstone, J.M. Taylor, Q.F. Wills, P.J. Kaisaki, A. Barrett, C. Camps, C. Fernandez, J. Ragoussis, D. Gauguier, M.I. Mccarthy, and C.M. Lindgren. 2009. MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes. BMC Medical Genomics 2: 54.
36. Horie, T.; K. Ono, H. Nishi, Y. Iwanaga, K. Nagao, M. Kinoshita, Y. Kuwabara, R. Takanabe, K. Hasegawa, T. Kita, and T. Kimura. 2009. MicroRNA-133 regulates the expression of GLUT4 by targeting KLF15 and is involved in metabolic control in cardiac myocytes. Biochemical and Biophysical Research Communications 389: 315-320.
37. Huang, B.; W. Qin, B. Zhao, Y. Shi, C. Yao, J. Li, H. Xiao, and Y. Jin. 2009. MicroRNA expression profiling in diabetic GK rat model. Acta Biochimica et Biophysica Sinica 41: 472-477.
38. Jiang, F.; X. Ye, X. Liu, L. Fincher, D. Mckearin, and Q. Liu. 2005. Dicer-1 and R3D1-L catalyze microRNA maturation in Drosophila. Genes & Development 19: 1674-1679.
39. Joglekar, M.V.; V.S. Parekh, S. Mehta, R.R. Bhonde, and A.A. Hardikar. 2007. MicroRNA profiling of developing and regenerating pancreas reveal post-transcriptional regulation of neurogenin3. Developmental Biology 311: 603-612.
40. John, B.; C. Sander, and D.S. Marks. 2006. Prediction of human microRNA targets. Methods in Molecular Biology 342: 101-113.
41. Jordan, S.D.; M. Kruger, D.M. Willmes, N. Redemann, F.T. Wunderlich, H.S. Bronneke, C. Merkwirth, H. Kashkar, V.M. Olkkonen, T. Bottger, T. Braun, J. Seibler, and J.C. Bruning. 2011. Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nature Cell Biology 13: 434-446.
42. Kahn, S.E.; R.L. Hull, and K.M. Utzschneider. 2006. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 444: 840-846.
43. Karbiener, M.; C. Fischer, S. Nowitsch, P. Opriessnig, C. Papak, G. Ailhaud, C. Dani, E.Z. Amri, and M. Scheideler. 2009. microRNA miR-27b impairs human adipocyte differentiation and targets PPARgamma. Biochemical and Biophysical Research Communications 390: 247-251.
44. Karbiener, M.; C. Neuhold, P. Opriessnig, A. Prokesch, J.G. Bogner-Strauss, and M. Scheideler. 2011. MicroRNA-30c promotes human adipocyte differentiation and co-represses PAI-1 and ALK2. RNA Biology 8: 850-860.
45. Karolina, D.S.; A. Armugam, S. Tavintharan, M.T. Wong, S.C. Lim, C.F. Sum, and K. Jeyaseelan. 2011. MicroRNA 144 impairs insulin signaling by inhibiting the expression of insulin receptor substrate 1 in type 2 diabetes mellitus. PLoS One 6: e22839.
46. Kim, V.N.; and J.W. Nam. 2006. Genomics of microRNA. Trends in Genetics 22: 165-173.
47. Kozomara, A.; and S. Griffiths-Jones. 2011. miRBase: Integrating microRNA annotation and deep-sequencing data. Nucleic Acids Research 39: D152-D157.
48. Krek, A.; D. Grun, M.N. Poy, R. Wolf, L. Rosenberg, E.J. Epstein, P. Macmenamin, I. Da Piedade, K.C. Gunsalus, M. Stoffel, and N. Rajewsky. 2005. Combinatorial microRNA target predictions. Nature Genetics 37: 495-500.
49. Krutzfeldt, J.; N. Rajewsky, R. Braich, K.G. Rajeev, T. Tuschl, M. Manoharan, and M. Stoffel. 2005. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438: 685-689.
50. Lee, R.C.; R.L. Feinbaum, and V. Ambros. 1993. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854.
51. Lee, Y.; C. Ahn, J. Han, H. Choi, J. Kim, J. Yim, J. Lee, P. Provost, O. Radmark, S. Kim, and V.N. Kim. 2003. The nuclear RNase III Drosha initiates microRNA processing. Nature 425: 415-419.
52. Lee, Y.; M. Kim, J. Han, K.H. Yeom, S. Lee, S.H. Baek, and V.N. Kim. 2004. MicroRNA genes are transcribed by RNA polymerase II. The EMBO Journal 23: 4051-4060.
53. Lewis, B.P.; C.B. Burge, and D.P. Bartel. 2005. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20.
54. Li, S.; X. Chen, H. Zhang, X. Liang, Y. Xiang, C. Yu, K. Zen, Y. Li, and C.Y. Zhang. 2009. Differential expression of microRNAs in mouse liver under aberrant energy metabolic status. Journal of Lipid Research 50: 1756-1765.
55. Li, Y.; X. Xu, Y. Liang, S. Liu, H. Xiao, F. Li, H. Cheng, and Z. Fu. 2010. miR-375 enhances palmitate-induced lipoapoptosis in insulin-secreting NIT-1 cells by repressing myotrophin (V1) protein expression. International Journal of Clinical and Experimental Pathology 3: 254-264.
56. Lin, Q.; Z. Gao, R.M. Alarcon, J. Ye, and Z. Yun. 2009. A role of miR-27 in the regulation of adipogenesis. The FEBS Journal 276: 2348-2358.
57. Ling, H.Y.; H.S. Ou, S.D. Feng, X.Y. Zhang, Q.H. Tuo, L.X. Chen, B.Y. Zhu, Z.P. Gao, C.K. Tang, W.D. Yin, L. Zhang, and D.F. Liao. 2009. Changes in microRNA profile and effects of miR-320 in insulin-resistant 3T3-L1 adipocytes. Clinical and Experimental Pharmacology & Physiology 36(9): e32-e39.
58. Lovis, P.; S. Gattesco, and R. Regazzi. 2008a. Regulation of the expression of components of the exocytotic machinery of insulin-secreting cells by microRNAs. Biological Chemistry 389: 305-312.
59. Lovis, P.; E. Roggli, D.R. Laybutt, S. Gattesco, J.Y. Yang, C. Widmann, A. Abderrahmani, and R. Regazzi. 2008b. Alterations in microRNA expression contribute to fatty acid-induced pancreatic beta-cell dysfunction. Diabetes 57: 2728-2736.
60. Lu, H.; R.J. Buchan, and S.A. Cook. 2010. MicroRNA-223 regulates Glut4 expression and cardiomyocyte glucose metabolism. Cardiovascular Research 86: 410-420.
61. Lund, E.; S. Guttinger, A. Calado, J.E. Dahlberg, and U. Kutay. 2004. Nuclear export of microRNA precursors. Science 303: 95-98.
62. Maassen, J.A.; T.H. Lm, E. Van Essen, R.J. Heine, G. Nijpels, R.S. Jahangir Tafrechi, A.K. Raap, G.M. Janssen, and H.H. Lemkes. 2004. Mitochondrial diabetes: Molecular mechanisms and clinical presentation. Diabetes 53(Suppl 1): S103-S109.
63. Maniataki, E.; and Z. Mourelatos. 2005. A human, ATP-independent, RISC assembly machine fueled by pre-miRNA. Genes & Development 19: 2979-2990.
64. Martinelli, R.; C. Nardelli, V. Pilone, T. Buonomo, R. Liguori, I. Castano, P. Buono, S. Masone, G. Persico, P. Forestieri, L. Pastore, and L. Sacchetti. 2010. miR-519d overexpression is associated with human obesity. Obesity (Silver Spring) 18: 2170-2176.
65. Marx, J. 2004. Medicine, metabolic defects tied to mitochondrial gene. Science 306: 592-593.
66. Merrins, M.J.; and E.L. Stuenkel. 2008. Kinetics of Rab27a-dependent actions on vesicle docking and priming in pancreatic beta-cells. The Journal of Physiology 586: 5367-5381.
67. Mersey, B.D.; P. Jin, and D.J. Danner. 2005. Human microRNA (miR29b) expression controls the amount of branched chain alpha-ketoacid dehydrogenase complex in a cell. Human Molecular Genetics 14: 3371-3377.
68. Mourelatos, Z.; J. Dostie, S. Paushkin, A. Sharma, B. Charroux, L. Abel, J. Rappsilber, M. Mann, and G. Dreyfuss. 2002. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes & Development 16: 720-728.
69. Najafi-Shoushtari, S.H.; F. Kristo, Y. Li, T. Shioda, D.E. Cohen, R.E. Gerszten, and A.M. Naar. 2010. MicroRNA-33 and the SREBP host genes cooperate to control cholesterol homeostasis. Science 328: 1566-1569.
70. Nakanishi, N.; Y. Nakagawa, N. Tokushige, N. Aoki, T. Matsuzaka, K. Ishii, N. Yahagi, K. Kobayashi, S. Yatoh, A. Takahashi, H. Suzuki, O. Urayama, N. Yamada, and H. Shimano. 2009. The up-regulation of microRNA-335 is associated with lipid metabolism in liver and white adipose tissue of genetically obese mice. Biochemical and Biophysical Research Communications 385: 492-496.
71. Nielsen, S.; C. Scheele, C. Yfanti, T. Akerstrom, A.R. Nielsen, B.K. Pedersen, and M.J. Laye. 2010. Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. The Journal of Physiology 588: 4029-4037.
72. Niu, W.; C. Huang, Z. Nawaz, M. Levy, R. Somwar, D. Li, P.J. Bilan, and A. Klip. 2003. Maturation of the regulation of GLUT4 activity by p38 MAPK during L6 cell myogenesis. The Journal of Biological Chemistry 278: 17953-17962.
73. Okamura, K.; A. Ishizuka, H. Siomi, and M.C. Siomi. 2004. Distinct roles for argonaute proteins in small RNA-directed RNA cleavage pathways. Genes & Development 18: 1655-1666.
74. Ortega, F.J.; J.M. Moreno-Navarrete, G. Pardo, M. Sabater, M. Hummel, A. Ferrer, J.I. Rodriguez-Hermosa, B. Ruiz, W. Ricart, B. Peral, and J.M. Fernandez-Real. 2010. MiRNA expression profile of human subcutaneous adipose and during adipocyte differentiation. PLoS One 5: e9022.
75. Park, S.Y.; J.H. Lee, M. Ha, J.W. Nam, and V.N. Kim. 2009. miR-29 miRNAs activate p53 by targeting p85 alpha and CDC42. Nature Structural & Molecular Biology 16: 23-29.
76. Patti, M.E.; and S. Corvera. 2010. The role of mitochondria in the pathogenesis of type 2 diabetes. Endocrine Reviews 31: 364-395.
77. Petersen, K.F.; and G.I. Shulman. 2006. Etiology of insulin resistance. American Journal of Medicine 119: S10-S16.
78. Pillai, R.S.; S.N. Bhattacharyya, and W. Filipowicz. 2007. Repression of protein synthesis by miRNAs: How many mechanisms? Trends in Cell Biology 17: 118-126.
79. Plaisance, V.; A. Abderrahmani, V. Perret-Menoud, P. Jacquemin, F. Lemaigre, and R. Regazzi. 2006. MicroRNA-9 controls the expression of granuphilin/Slp4 and the secretory response of insulin-producing cells. The Journal of Biological Chemistry 281: 26932-26942.
80. Poy, M.N.; L. Eliasson, J. Krutzfeldt, S. Kuwajima, X. Ma, P.E. Macdonald, S. Pfeffer, T. Tuschl, N. Rajewsky, P. Rorsman, and M. Stoffel. 2004. A pancreatic islet-specific microRNA regulates insulin secretion. Nature 432: 226-230.
81. Poy, M.N.; J. Hausser, M. Trajkovski, M. Braun, S. Collins, P. Rorsman, M. Zavolan, and M. Stoffel. 2009. miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proceedings of the National Academy of Sciences of the United States of America 106: 5813-5818.
82. Ramachandran, D.; U. Roy, S. Garg, S. Ghosh, S. Pathak, and U. Kolthur-Seetharam. 2011. Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic beta-islets. The FEBS Journal 278: 1167-1174.
83. Rodriguez, A.; S. Griffiths-Jones, J.L. Ashurst, and A. Bradley. 2004. Identification of mammalian microRNA host genes and transcription units. Genome Research 14: 1902-1910.
84. Roggli, E.; A. Britan, S. Gattesco, N. Lin-Marq, A. Abderrahmani, P. Meda, and R. Regazzi. 2010. Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 59: 978-986.
85. Rottiers, V.; and A.M. Naar. 2012. MicroRNAs in metabolism and metabolic disorders. Nature Reviews Molecular Cell Biology 13: 239-250.
86. Rottiers, V.; S.H. Najafi-Shoushtari, F. Kristo, S. Gurumurthy, L. Zhong, Y. Li, D.E. Cohen, R.E. Gerszten, N. Bardeesy, R. Mostoslavsky, and A.M. Naar. 2011. MicroRNAs in metabolism and metabolic diseases. Cold Spring Harbor Symposia on Quantitative Biology 76: 225-233.
87. Ryu, H.S.; S.Y. Park, D. Ma, J. Zhang, and W. Lee. 2011. The induction of microRNA targeting IRS-1 is involved in the development of insulin resistance under conditions of mitochondrial dysfunction in hepatocytes. PLoS One 6: e17343.
88. Sacco, J.; and K. Adeli. 2012. MicroRNAs: emerging roles in lipid and lipoprotein metabolism. Current Opinion in Lipidology 23: 220-225.
89. Saito, K.; A. Ishizuka, H. Siomi, and M.C. Siomi. 2005. Processing of pre-microRNAs by the Dicer-1-loquacious complex in Drosophila cells. PLoS Biology 3: e235.
90. Samuel, V.T.; and G.I. Shulman. 2012. Mechanisms for insulin resistance: Common threads and missing links. Cell 148: 852-871.
91. Sandhu, M.S.; A.H. Heald, J.M. Gibson, J.K. Cruickshank, D.B. Dunger, and N.J. Wareham. 2002. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: A prospective observational study. Lancet 359: 1740-1745.
92. Sekine, S.; R. Ogawa, R. Ito, N. Hiraoka, M.T. Mcmanus, Y. Kanai, and M. Hebrok. 2009a. Disruption of Dicer1 induces dysregulated fetal gene expression and promotes hepatocarcinogenesis. Gastroenterology 136(2304-2315): e1-e4.
93. Sekine, S.; R. Ogawa, M.T. Mcmanus, Y. Kanai, and M. Hebrok. 2009b. Dicer is required for proper liver zonation. The Journal of Pathology 219: 365-372.
94. Shaw, J.E.; R.A. Sicree, and P.Z. Zimmet. 2010. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Research and Clinical Practice 87: 4-14.
95. Stump, C.S.; E.J. Henriksen, Y. Wei, and J.R. Sowers. 2006. The metabolic syndrome: Role of skeletal muscle metabolism. Annals of Medicine 38: 389-402.
96. Sun, L.L.; B.G. Jiang, W.T. Li, J.J. Zou, Y.Q. Shi, and Z.M. Liu. 2011. MicroRNA-15a positively regulates insulin synthesis by inhibiting uncoupling protein-2 expression. Diabetes Research and Clinical Practice 91: 94-100.
97. Szendroedi, J.; E. Phielix, and M. Roden. 2012. The role of mitochondria in insulin resistance and type 2 diabetes mellitus - nature reviews. Endocrinology 8: 92-103.
98. Takanabe, R.; K. Ono, Y. Abe, T. Takaya, T. Horie, H. Wada, T. Kita, N. Satoh, A. Shimatsu, and K. Hasegawa. 2008. Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochemical and Biophysical Research Communications 376: 728-732.
99. Tang, X.; L. Muniappan, G. Tang, and S. Ozcan. 2009. Identification of glucose-regulated miRNAs from pancreatic beta cells reveals a role for miR-30d in insulin transcription. RNA 15: 287-293.
100. Tang, X.; G. Tang, and S. Ozcan. 2008. Role of microRNAs in diabetes. Biochimica et Biophysica Acta 1779: 697-701.
101. Trajkovski, M.; J. Hausser, J. Soutschek, B. Bhat, A. Akin, M. Zavolan, M.H. Heim, and M. Stoffel. 2011. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 474: 649-653.
102. Tsai, W.C.; S.D. Hsu, C.S. Hsu, T.C. Lai, S.J. Chen, R. Shen, Y. Huang, H.C. Chen, C.H. Lee, T.F. Tsai, M.T. Hsu, J.C. Wu, H.D. Huang, M.S. Shiao, M. Hsiao, and A.P. Tsou. 2012. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. The Journal of Clinical Investigation 122: 2884-2897.
103. Tyagi, A.C.; U. Sen, and P.K. Mishra. 2011. Synergy of microRNA and stem cell: A novel therapeutic approach for diabetes mellitus and cardiovascular diseases. Current Diabetes Reviews 7: 367-376.
104. Van Rooij, E. 2011. The art of microRNA research. Circulation Research 108: 219-234.
105. Wijesekara, N.; L.H. Zhang, M.H. Kang, T. Abraham, A. Bhattacharjee, G.L. Warnock, C.B. Verchere, and M.R. Hayden. 2012. miR-33a modulates ABCA1 expression, cholesterol accumulation, and insulin secretion in pancreatic islets. Diabetes 61: 653-658.
106. Wilfred, B.R.; W.X. Wang, and P.T. Nelson. 2007. Energizing miRNA research: A review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Molecular Genetics and Metabolism 91: 209-217.
107. Xie, H.; B. Lim, and H.F. Lodish. 2009. MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes 58: 1050-1057.
108. Yu, X.Y.; Y.H. Song, Y.J. Geng, Q.X. Lin, Z.X. Shan, S.G. Lin, and Y. Li. 2008. Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Biochemical and Biophysical Research Communications 376: 548-552.
109. Zampetaki, A.; S. Kiechl, I. Drozdov, P. Willeit, U. Mayr, M. Prokopi, A. Mayr, S. Weger, F. Oberhollenzer, E. Bonora, A. Shah, J. Willeit, and M. Mayr. 2010. Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circulation Research 107: 810-817.
110. Zaragosi, L.E.; B. Wdziekonski, K.L. Brigand, P. Villageois, B. Mari, R. Waldmann, C. Dani, and P. Barbry. 2011. Small RNA sequencing reveals miR-642a-3p as a novel adipocyte-specific microRNA and miR-30 as a key regulator of human adipogenesis. Genome Biology 12: R64.